NumFin

Relief Therapeutics Holding AG

符号: 0QKQ.L

LSE

1.2

CHF

今天的市场价格

  • -0.1533

    市盈率

  • -0.0017

    PEG比率

  • 14.91M

    MRK市值

  • 0.00%

    DIV收益率

Relief Therapeutics Holding AG (0QKQ-L) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Relief Therapeutics Holding AG (0QKQ.L). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Relief Therapeutics Holding AG 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015

balance-sheet.row.cash-and-short-term-investments

014.619.244.8
43.2
0.1
0.3
0.1
0.4
0

balance-sheet.row.short-term-investments

0000
0.2
0
0
0
0
0

balance-sheet.row.net-receivables

02.82.32.7
0.1
0.1
0
0
0
0.2

balance-sheet.row.inventory

00.60.20.4
0
0
0
0
0
0

balance-sheet.row.other-current-assets

00.40.97.1
3.6
0
0.1
0
0.2
-0.2

balance-sheet.row.total-current-assets

018.322.655
46.9
0.3
0.4
0.2
0.6
0

balance-sheet.row.property-plant-equipment-net

032.72.5
0
0
0
0
0
0

balance-sheet.row.goodwill

00.578.7
0
0
0
0
0
18.8

balance-sheet.row.intangible-assets

054.4162.9192.3
30.8
19.6
35.2
30.8
30.8
0

balance-sheet.row.goodwill-and-intangible-assets

054.4169.9201
30.8
19.6
35.2
30.8
30.8
18.8

balance-sheet.row.long-term-investments

053.9-7-8.7
0.4
0
0
0
0
0

balance-sheet.row.tax-assets

00.60.51.7
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0-53.80.10.1
0
-19.6
-35.2
-30.8
-30.8
-18.8

balance-sheet.row.total-non-current-assets

058.1166.2196.6
31.2
19.6
35.2
30.8
30.8
18.8

balance-sheet.row.other-assets

0000
0
0
0
0
0
-18.8

balance-sheet.row.total-assets

076.4188.8251.6
78
19.9
35.6
31
31.4
0

balance-sheet.row.account-payables

011.61.7
1.4
0.3
0.1
0.5
0.4
0.4

balance-sheet.row.short-term-debt

02.22.11.7
0.9
1.7
1.1
1
0.9
0

balance-sheet.row.tax-payables

000.30.5
0.4
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0000.4
0
0
0
0
0
0

Deferred Revenue Non Current

02.12.22.2
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-

balance-sheet.row.other-current-liab

03.66.215.9
6.3
0.8
0.7
0.5
0.4
-0.3

balance-sheet.row.total-non-current-liabilities

017.332.750.4
4.3
2.7
12.3
8
7.5
0.7

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
-0.7

balance-sheet.row.capital-lease-obligations

02.12.22.2
0
0
0
0
0
0

balance-sheet.row.total-liab

024.243.470.1
11
5.6
14.3
10
9.2
0.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0

balance-sheet.row.common-stock

056.256.244.1
32.5
21.1
20.9
20.1
19.5
6.5

balance-sheet.row.retained-earnings

0-218.3-119.6-69.8
-35.2
-27.5
-20.5
-20.1
-17.8
-0.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

06.25.32.6
1.2
0.2
0.2
0.2
0.1
-6.3

balance-sheet.row.other-total-stockholders-equity

0208.2203.6204.5
68.5
20.5
20.7
20.8
20.5
-0.1

balance-sheet.row.total-stockholders-equity

052.2145.4181.5
67
14.3
21.3
20.9
22.2
-0.1

balance-sheet.row.total-liabilities-and-stockholders-equity

076.4188.8251.6
78
19.9
35.6
31
31.4
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0

balance-sheet.row.total-equity

052.2145.4181.5
67
14.3
21.3
20.9
22.2
-0.1

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-

Total Investments

053.9-7-8.7
0.4
0
0
0
0
0

balance-sheet.row.total-debt

04.34.34.3
0.9
1.7
1.1
1
0.9
0

balance-sheet.row.net-debt

0-10.2-14.9-40.5
-42.3
1.6
0.8
0.9
0.5
0

现金流量表

在 Relief Therapeutics Holding AG 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015

cash-flows.row.net-income

0-50.8-34.7-7.8
-7.5
-0.4
-2.9
-16.8
-0.1

cash-flows.row.depreciation-and-amortization

03.920.1
0
0
0
0
0

cash-flows.row.deferred-income-tax

0-3.5-0.81.6
-4.7
0.1
1
-0.6
0

cash-flows.row.stock-based-compensation

02.21.11
0.2
0
0.1
0.4
0

cash-flows.row.change-in-working-capital

05.6-5.20
0
-0.2
0
0.1
0.1

cash-flows.row.account-receivables

00-0.20
0
0
0
0.1
1.9

cash-flows.row.inventory

00.2-0.10
0
0
-0.4
0.6
-0.7

cash-flows.row.account-payables

0-0.1-0.81.2
0.2
-0.4
0.1
-0.3
-1.1

cash-flows.row.other-working-capital

05.5-4.1-1.2
-0.2
0.2
-0.1
0.3
0

cash-flows.row.other-non-cash-items

018.61.9-13.1
11.2
-0.2
0.7
13.4
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-0.5-13.70
0
0
0
0
-0.5

cash-flows.row.acquisitions-net

0-7.9-16.70
0
0
0
0.1
0

cash-flows.row.purchases-of-investments

0000
0
0
0
-0.1
0

cash-flows.row.sales-maturities-of-investments

00.50.13.3
0
0
0
0
0

cash-flows.row.other-investing-activites

000-0.2
0
0
0
0
0.5

cash-flows.row.net-cash-used-for-investing-activites

0-8-30.33
0
0
0
0.1
-0.5

cash-flows.row.debt-repayment

0-0.1-5.6-0.5
-0.6
0
0
0
0

cash-flows.row.common-stock-issued

07.176.158.3
0
0.7
0.9
2.8
0

cash-flows.row.common-stock-repurchased

0-0.2-2.8-0.6
0
0
0
0
0

cash-flows.row.dividends-paid

0-6.8-67.7-58.2
0
0
0
0
0

cash-flows.row.other-financing-activites

06.467.758.2
0.6
0
0
0.3
0

cash-flows.row.net-cash-used-provided-by-financing-activities

06.467.758.2
0.6
0.7
0.9
3.1
0

cash-flows.row.effect-of-forex-changes-on-cash

00.2-0.10.1
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-25.51.643
-0.1
0.1
-0.3
0.4
0

cash-flows.row.cash-at-end-of-period

019.244.843.2
0.1
0.3
0.1
0.4
0

cash-flows.row.cash-at-beginning-of-period

044.843.20.1
0.3
0.1
0.4
0
0

cash-flows.row.operating-cash-flow

0-24.1-35.7-18.2
-0.7
-0.6
-1.2
-2.9
0

cash-flows.row.capital-expenditure

0-0.5-13.70
0
0
0
0
-0.5

cash-flows.row.free-cash-flow

0-24.6-49.4-18.2
-0.7
-0.6
-1.2
-2.9
-0.5

利润表行

Relief Therapeutics Holding AG 的收入与上期相比变化了 NaN%。据报告, 0QKQ.L 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015

income-statement-row.row.total-revenue

066.13.3
0
0
0.6
0
0
0

income-statement-row.row.cost-of-revenue

016.918.111.9
0
0
0.1
0.1
0.2
0.1

income-statement-row.row.gross-profit

0-10.9-12-8.6
0
0
0.5
-0.1
-0.2
-0.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-0.2-1.3-0.7
-0.2
0
0
0
0
0

income-statement-row.row.operating-expenses

0924.526.6
19.3
0.9
0.8
1.7
16.6
0

income-statement-row.row.cost-and-expenses

025.942.638.5
19.3
0.9
0.8
1.8
16.8
0.1

income-statement-row.row.interest-income

00.100
0
0.1
0.1
0.1
0
0

income-statement-row.row.interest-expense

00.20.20.3
0.2
0.1
0.1
0.1
0.3
0.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-91.8-17.8-0.3
13
-11.2
0.1
-0.2
-14.9
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-0.2-1.3-0.7
-0.2
0
0
0
0
0

income-statement-row.row.total-operating-expenses

0-91.8-17.8-0.3
13
-11.2
0.1
-0.2
-14.9
0

income-statement-row.row.interest-expense

00.20.20.3
0.2
0.1
0.1
0.1
0.3
0.1

income-statement-row.row.depreciation-and-amortization

03.33.92
0
0
0
0
0
0.1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-

income-statement-row.row.operating-income

0-19.9-36.5-35.2
-19.3
-0.9
-0.5
-1.7
-1.9
-0.1

income-statement-row.row.income-before-tax

0-111.7-54.3-35.5
-6.3
-12.2
-0.4
-1.9
-16.8
-0.1

income-statement-row.row.income-tax-expense

0-13.5-3.5-0.8
1.6
-4.7
0
1
0
-0.1

income-statement-row.row.net-income

0-98.2-50.8-34.7
-7.8
-7.5
-0.4
-2.9
-16.8
-0.1
类似股票
您可能还对以下内容感兴趣：
0HL9.L
Affimed N.V..
5.31 USD
LSE
0J2O.L
Halozyme Therapeutics, Inc..
43.365 USD
LSE
0T6G.L
Homology Medicines, Inc..
21.56 USD
LSE
W8A.DE
Walgreens Boots Alliance Inc.
15.964 EUR
XETRA
0UNL.L
Nektar Therapeutics.
1.65 USD
LSE
0OCQ.L
Transgene SA.
1.248 EUR
LSE
0RD1.L
Camurus AB (publ).
504.2706 SEK
LSE
0HOJ.L
Blueprint Medicines Corporation.
91.075 USD
LSE
0574.HK
Pa Shun International Holdings Limited.
0.05 HKD
HKSE
0JDB.L
Invitae Corporation.
0.0035 USD
LSE

常见问题

什么是 Relief Therapeutics Holding AG (0QKQ.L) 总资产是多少？

Relief Therapeutics Holding AG (0QKQ.L) 总资产为 76390000.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 -1.800.

什么是公司自由现金流？

自由现金流为 -1.433.

什么是企业净利润率？

净利润率为 -16.274.

企业总收入是多少？

总收入为 -3.299.

什么是 Relief Therapeutics Holding AG (0QKQ.L) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 -98181000.000.

公司总债务是多少？

债务总额为 4311000.000.

营业费用是多少？

运营支出为 9045000.000.

公司现金是多少？

企业现金为 0.000.